Rockefeller University Press ‘Read & Publish’ 1 year Agreement 2021

  • Start: 1 Mar 2021
    Expiry: 28 Feb 2022
  • Description:

    An unlimited Read & Publish transitional Agreement covering the three Rockefeller University Press hybrid journals.

Product overview

Rockefeller University Press' Read and Publish Transitional Agreement is an all-inclusive product. For a set, annual up-front fee, participating institutions receive unlimited access to all paywalled content, back to Volume 1 Issue 1 of the Press' three hybrid journals, plus unlimited, immediate open access publishing of the Version of Record for all corresponding authors at participating institutions under CC-BY licence terms in each journal.

Journal of Cell Biology (JCB) publishes advances in any area of basic cell biology, as well as applied cellular advances in fields such as immunology, neurobiology, metabolism, microbiology, developmental biology and plant biology. The journal was established in 1955. For high level metrics, please see https://rupress.org/JCB/pages/journal-metrics.

Journal of Experimental Medicine (JEM) publishes papers providing novel conceptual insight into immunology, neuroscience, cancer biology, vascular biology, microbial pathogenesis and stem cell biology. The journal was established in 1896. For high level metrics, please see https://rupress.org/JEM/pages/journal-metrics.

Journal of General Physiology (JGP) publishes mechanistic and quantitative cellular and molecular physiology of the highest quality. The journal was established in 1918. For high level metrics, please see https://rupress.org/JGP/pages/journal-metrics.

Update Type

Information not available.

Update Notes

Information not available.